outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.2195182961,0.0281527644,1.7116714239,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.3515390706,0.1710118015,0.7226385376,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,1.349426786,0.8548868243,2.1300511354,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.3850074399,0.0491862025,3.013664834,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4823283321,0.2223858996,1.0461122777,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.1776278813,0.9830311801,4.823919409,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.385516989,0.0492029877,3.0206163453,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4781535868,0.220349829,1.0375812571,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.2059269715,0.9871498687,4.9294579856,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.3842935277,0.049192008,3.0021444812,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4820076062,0.2224094718,1.0446107826,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.1717532256,0.9565667692,4.9306668648,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.3849868845,0.0491835166,3.0135076034,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4822356388,0.2223328343,1.0459598201,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.1796787838,0.9820505306,4.8378361931,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.384801556,0.049196313,3.0098238735,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4777157624,0.2203249398,1.0357989882,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.2011254828,0.9647092021,5.0221905009,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,837,1763,0.3851851399,0.0491119724,3.0210065843,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3917,6296,0.4707046258,0.2169147934,1.0214280052,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1104,5160,2.235488928,1.0028722588,4.9830980001,1,1
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.0525703393,0.5798504547,1.9106725024,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.8952621719,0.6166496508,1.2997564425,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.1477011757,0.9355102027,1.4080209759,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7870553875,0.8263792469,3.8645294763,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9294302688,0.5968152195,1.4474172179,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.103885874,0.7795955192,1.5630721225,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7854205853,0.8255358971,3.8614028508,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9302769927,0.597369688,1.4487097363,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.1063040748,0.7804173107,1.568274677,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7415094021,0.8051573169,3.766785613,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9195303447,0.5904619848,1.4319906728,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.067361787,0.7487865795,1.5214765001,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7865881865,0.8260845158,3.8638871534,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.928098977,0.5961134128,1.4449728737,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.1108338642,0.7823933089,1.577150341,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7444153331,0.8066682829,3.772287716,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.920572617,0.5914248188,1.4329022325,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0850865103,0.7567977843,1.5557824815,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.7692928761,0.8175148867,3.8291624195,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9233060033,0.5924007205,1.4390495255,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.1107006497,0.781903753,1.5777593194,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.2906454841,0.1594418561,0.5298156925,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.5734208495,0.4394875292,0.7481701956,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.7354564579,0.6018905605,0.8986620442,1,1
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.4029364283,0.1730038655,0.938463223,1,1
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7173785506,0.523931071,0.9822513177,1,1
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.6321079537,0.4755311849,0.8402402993,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.4028247611,0.1728794985,0.938617879,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7188920039,0.5250301573,0.9843352922,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.6329900883,0.4765822917,0.8407287867,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.3947196416,0.1700028542,0.916476351,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7107398389,0.5191293572,0.9730736888,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.6100053634,0.4607037067,0.8076916637,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.4028805201,0.1729806962,0.9383284782,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7193582938,0.5253633623,0.9849875189,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.6301342775,0.4743827832,0.8370228046,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.3951614099,0.1701321429,0.9178309119,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7140106879,0.5216039306,0.9773915275,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.6061623133,0.4586898138,0.8010484188,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,829,1752,0.396065329,0.1704489495,0.9203209831,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3883,6221,0.7080033763,0.517007869,0.9695573528,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1030,4908,0.624592545,0.4699663983,0.8300930635,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,0.3884056841,0.1499230965,1.0062423929,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.6466197544,0.4161195368,1.0048004713,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,0.8434646199,0.6691662521,1.0631626487,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.4013047678,0.41117965,4.7756620554,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.8572834,0.5109104389,1.4384807435,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.0853328772,0.7487012462,1.5733210812,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.403829763,0.4114190703,4.7900988202,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.8603852958,0.5126655573,1.4439488799,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.091200358,0.7503763295,1.5868280681,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.3749821252,0.4050153605,4.6679114643,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.8515818253,0.5079028987,1.4278154487,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.0518643788,0.7221530112,1.5321111376,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.4013860357,0.4112481972,4.7754198911,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.8580929476,0.5114557706,1.4396621351,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.0750973931,0.742675767,1.5563109179,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.3795987132,0.4060697362,4.6871077544,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.8554505648,0.5102421663,1.4342124525,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.0460154885,0.7167924135,1.5264508684,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,830,1760,1.4078078482,0.4148602205,4.7773270122,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3902,6277,0.857241166,0.5109740699,1.4381598988,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1058,5050,1.1015881745,0.7547607159,1.6077897017,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.2301664266,0.0540815102,0.9795692427,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.5021239062,0.3253245142,0.7750058975,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,0.9120738607,0.721113732,1.1536026711,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1265615296,0.0276070073,0.5802085165,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7788677466,0.4361904204,1.3907571974,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1455415078,0.7581858643,1.7307963759,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1259131174,0.0273074006,0.5805793583,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7826125005,0.4379077706,1.3986559888,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1468598325,0.7584077917,1.7342747395,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1239952396,0.0269969413,0.5695022729,1,1
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7729851868,0.4329642476,1.380035655,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1131628054,0.7288712567,1.7000690039,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1265602155,0.0276067189,0.5802025303,1,1
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7787922806,0.4363895132,1.3898533259,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1457949649,0.7586418347,1.7305216263,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1238351319,0.0268126809,0.5719360909,1,1
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7779408948,0.4357852949,1.3887390026,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1144742725,0.7294932091,1.7026243543,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,836,1763,0.1254546112,0.0272012128,0.5786087412,1,1
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3905,6288,0.7770172675,0.4367052176,1.3825248925,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5071,1.1606139527,0.7675666594,1.7549286836,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,6.4915999893,0.6769843414,62.247924869,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8990523205,0.4399705686,1.8371571482,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.8704335739,0.6008615672,1.2609470266,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.434653173,1.5768912284,151.07479469,1,1
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8689072514,0.4071775852,1.8542273419,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.777584661,0.4573435509,1.3220650074,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.508539126,1.5815258861,152.07767886,1,1
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8701146826,0.4078112505,1.8564950329,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.7882607949,0.4627377284,1.342780246,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.055323671,1.5348004856,147.68223816,1,1
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8611827431,0.4037319842,1.8369506162,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.7530027787,0.4408367668,1.2862202689,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.434602524,1.5768860984,151.07429466,1,1
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8689445956,0.4072051534,1.8542611851,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.7776990792,0.4570426723,1.3233247012,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.199395077,1.5466315456,149.37081258,1,1
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8629879976,0.4045659979,1.8408573333,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.7657333406,0.448105319,1.3085038808,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,839,1765,15.561060209,1.5902178196,152.27259552,1,1
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3918,6302,0.8642068811,0.4056963004,1.8409177813,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1097,5153,0.7985656139,0.4665316265,1.3669106304,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,0.8249505005,0.5448514285,1.2490438543,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9708091895,0.8353044245,1.1282958103,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,0.9107124659,0.805580464,1.0295646837,1,0
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2740600008,1.1413252641,4.5310036058,1,1
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9447854093,0.785201364,1.1368032591,1,0
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0089483261,0.8247770755,1.2342446885,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2570175239,1.1310453342,4.5039115137,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9447879481,0.7847954623,1.1373973345,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0070379789,0.8231754447,1.231967617,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2906100806,1.1499384817,4.5627610735,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9480733166,0.7877715192,1.1409945545,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0189157484,0.8312601975,1.2489342152,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2768610243,1.1431614247,4.5348767132,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.94217548,0.7839970863,1.1322677732,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0066423422,0.8200117116,1.2357491859,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2681198883,1.1370788465,4.5241962275,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.943590421,0.7845989375,1.1348000105,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0102712471,0.8228594279,1.24036738,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.2482166855,1.1243953706,4.4952855526,1,1
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,0.9403461341,0.7808583503,1.1324087802,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.0076616084,0.8229901462,1.2337716577,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,2.1781171283,0.7644419597,6.2060881988,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,2.1083244277,1.4442273399,3.0777923735,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,2.2570555664,1.554274341,3.2776065945,1,1
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.565397207,0.5267095282,4.6524095053,1,0
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4861455924,0.9470083956,2.3322166223,1,0
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7459938046,1.0185252182,2.9930475075,1,1
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.5451851506,0.5187855946,4.6022811245,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4690361917,0.9343562132,2.309683718,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7543711348,1.0220753862,3.0113415508,1,1
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.5519082132,0.5211840726,4.6210527701,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4817807866,0.9440084892,2.3259052484,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7283273003,1.0027653804,2.9788775274,1,1
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.5653816579,0.5267011317,4.6523912473,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4867125404,0.9472794448,2.3333285545,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7464049938,1.0187478223,2.9938031138,1,1
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.5297148563,0.5125574895,4.5653952765,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4650675148,0.9316166563,2.3039764354,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7375358909,1.0069697788,2.9981346371,1,1
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,840,1765,1.5398975747,0.5165732899,4.5904126033,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3922,6307,1.4634000718,0.9300220342,2.3026763791,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1110,5191,1.7789922862,1.0380064937,3.048934254,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.584236942,0.8680546662,2.8913002672,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.4929210776,1.1073634418,2.0127207201,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,1.8983206646,1.2128476348,2.9712069697,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.7993934681,0.8979975531,3.6055965208,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.5753667854,1.1271748751,2.2017706065,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,1.997876329,1.0808405438,3.6929682633,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.8033647967,0.8992017725,3.6166794699,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.579391952,1.1295309711,2.2084201337,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,2.0070075568,1.0825826686,3.7208053017,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.7828461921,0.8882409446,3.5784665906,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.5706998695,1.1235535886,2.195799208,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,1.9709076996,1.0620613376,3.6574885299,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.799428321,0.8980065521,3.605700064,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.5782136429,1.1292343316,2.205705435,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,1.9984231941,1.0819499747,3.6912014013,1,1
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.7899631281,0.8905275492,3.5978314233,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.5778513118,1.1282513653,2.2066135604,1,1
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,1.9793603033,1.0628690636,3.6861240434,1,1
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,798,1745,1.8040086734,0.9001226972,3.6155596384,1,0
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3751,6196,1.5744761898,1.1264676111,2.2006627159,1,1
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1060,5159,2.0009978793,1.0748436364,3.7251860433,1,1
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,0.8517546471,0.3776162563,1.9212254949,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,1.0611139709,0.7842416375,1.4357346069,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,2.0129041888,1.3446976937,3.0131555162,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,1.0013826476,0.372122557,2.6947229833,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9429578974,0.6556655427,1.3561328732,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.6043954028,0.9539350342,2.6983856513,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,1.000011895,0.3710531967,2.6950954718,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9406259037,0.6534128149,1.3540859172,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.6090199548,0.9564866496,2.7067238375,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,0.9968019623,0.3701791967,2.6841436821,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9415698221,0.6541378855,1.3553009993,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.5959126186,0.9513993886,2.6770430133,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,1.0014006209,0.3721315062,2.6947549102,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9438280209,0.6563205009,1.3572809805,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.6062769048,0.9550861941,2.7014582671,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,0.9963751806,0.3695381188,2.686498226,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9401969618,0.6526379542,1.3544574313,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.6025656728,0.9552243856,2.6886004737,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,820,1754,0.9966925279,0.3700419552,2.684549634,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3825,6260,0.9353745731,0.6501326791,1.3457646727,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,1070,5142,1.605858033,0.9537657054,2.7037877413,1,0
